Form 4: Guardant Health Co-CEO AmirAli Talasaz Reports Stock Transactions

AmirAli Talasaz, Co-CEO of Guardant Health, reports the acquisition and disposal of common stock related to the vesting of restricted stock units.

Summary

• On September 30, 2024, AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., engaged in transactions involving the company's common stock.
• Talasaz acquired 11,461 shares of common stock through the vesting of restricted stock units.
• Simultaneously, 5,809 shares were disposed of to cover tax withholding obligations related to the vesting.
• Following these transactions, Talasaz directly owns 2,204,432 shares of Guardant Health common stock.
• The shares were disposed of at a price of $22.94.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when company insiders, like the Co-CEO of Guardant Health, engage in transactions involving the company's stock. It provides transparency to investors regarding the trading activities of key personnel.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.

Key Dates